J. App. Microbiol. 2003, 94, 273-279.

Development of an immunomagnetic separation polymerase chain reaction (IMS-PCR) assay specific of Enterocytozoon bieneusi from environnemental water samples.

Eur. J. Med. Chem. 2003, 38, 711-718.

Synthesis and antileismanial activity of new imidazolidin-2-one derivatives.

Eur. J. Med. Chem. 2003, 38, 75-87.

Synthesis and antifungal activity of new 1-halogenobenzyl-3-imidazolylmethylindole derivatives.

Biomédica Bogotá: Instituto Nacional de Salud 2003, 23, 46-49.

Actividad leishmaniada de derivados de la imidazolidin-2-ona y su efecto sobre pkc y fosfatasa ácida de leishmania spp.

Bioorg. Med. Chem. Lett. 2003, 13, 1553-1555.

Preparation and Pharmacological Profile of 7-(a-Azolylbenzyl)-1H-Indoles and Indolines as New Aromatase Inhibitors.

Acta Parasitologica 2003, 48, 301-305.

A new fluorometric method for anti-Leishmania drug screening on axenic amastigotes.

J. Enz. Inh. Med. Chem. 2003, 18, 155-158.

Retinoic acid metabolism inhibition by 3-azolylmethyl-1H-indoles and 2,3 or 5-(a-azolylbenzyl)-1H-indoles.

Prenat Diagn. 2003, 23, 558-560.

Fetal Toxoplasmosis and negative amniocentesis: necessity of an ultrasound follow-up.

J. Enz. Inh. Med. Chem. 2003, 18, 201-208.

New N-pyridinyl (methyl) N1-substituted-3-indolylpropanamides acting as topical and systemic inflammation inhibitors.

Eur. J. Clin. Microbiol. Infect. Dis. 2003, 22, 181-184.

Cellular immunity to Toxoplasma gondii in congenitally infected newborn and immunocompetent infected hosts.

J. Enz. Inh. Med. Chem. 2003, 18, 253-257.

Potential Inhibitors of Angiogenesis. Part II: 3-(Azolylmethylene)-2,3-dihydrobenzo[b]furan-2-ones.

J. Enz. Inh. Med. Chem. 2003, 18, 243-252. 

Potential Inhibitors of Angiogenesis. Part I: 3-(Imidazol-4(5)-yl methylene)indolin-2-ones.